Product Information

IMIQUIMOD 5% CREAM PACKET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $12.8930 per EA under NDC 45802036853. Its NADAC has been published 474 times since Nov 28, 2013.

FDA first approved this application on Sep 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IMIQUIMOD 5% CREAM PACKET

Imiquimod
$12.8930per EA

Strength

12.5 mg/.25g

NDC

45802036853

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

IMIQUIMOD

Approval Type

Generic (ANDA)

FDA Application

ANDA078837

FDA Approved

9/7/2010

TE Code

AB

On Market Since

11/9/2010

Pharmacological Classes

Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers

Price Statistics

The NADAC for IMIQUIMOD 5% CREAM PACKET has been published 474 times since Nov 28, 2013, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.

Current price$12.8930 per EA
All-time high$14.2358 (Dec 11, 2013)
All-time low$8.4277 (Feb 17, 2016)
52-week high$12.8930
52-week low$10.2092
Median price$11.6746
Average price$11.6502
Largest weekly change+26.0% (Mar 23, 2016)
Weeks tracked474
Tracking sinceNov 28, 2013

Price History

1W

+3.7%

1M

+6.0%

3M

+6.2%

6M

+8.2%

1Y

+26.3%

3Y

-0.7%

5Y

-0.7%

All

-9.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 95%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMIQUIMOD 5% CREAM PACKET?

The current National Average Drug Acquisition Cost (NADAC) for IMIQUIMOD 5% CREAM PACKET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $12.8930 per EA (NDC 45802036853), effective Nov 18, 2026.

How has the price of IMIQUIMOD 5% CREAM PACKET changed over time?

Over the history we have for it, the NADAC for IMIQUIMOD 5% CREAM PACKET has declined 9.4%. It has been tracked across 474 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for IMIQUIMOD 5% CREAM PACKET?

Since Nov 28, 2013, the NADAC for IMIQUIMOD 5% CREAM PACKET has ranged from a low of $8.4277 (Feb 17, 2016) to a high of $14.2358 (Dec 11, 2013), with a median of $11.6746 per EA.

Are there cheaper alternatives to IMIQUIMOD 5% CREAM PACKET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMIQUIMOD 5% CREAM PACKET, is $0.6119 per EA — about 95% below IMIQUIMOD 5% CREAM PACKET.

Who manufactures IMIQUIMOD 5% CREAM PACKET?

IMIQUIMOD 5% CREAM PACKET (NDC 45802036853) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.